16 Jul 2026 by admin in UncategorizedComments Jasper Therapeutics Announces Merger with Kira Pharmaceuticals
15 Jul 2026 by admin in UncategorizedComments Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026
14 Jul 2026 by admin in UncategorizedComments NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
30 Jun 2026 by admin in UncategorizedComments Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1
29 Jun 2026 by admin in UncategorizedComments Alebund Pharmaceuticals (09637.HK) Debuts on the HKEx Main Board
09 Jun 2026 by admin in UncategorizedComments Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long- Acting Anti-TSLP Antibody WIN378
08 Jun 2026 by admin in UncategorizedComments OriCell’s GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma
08 Jun 2026 by admin in UncategorizedComments China NMPA Grants IND Clearance to Adcentrx Therapeutics’ ADRX-0405 STEAP1 ADC for the Treatment of Late-Stage Solid Tumors, Including Prostate Cancer
04 Jun 2026 by admin in UncategorizedComments Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
01 Jun 2026 by admin in UncategorizedComments Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement
